We leverage our deep clinical and commercial expertise, supported by an intensive, field-oriented research approach, to address the most complex business challenges. Explore our unique perspectives, innovative methodologies, and the critical insights we provide to help our clients navigate their most pressing issues. Explore our collection of Insights and Resources below to learn more about our unique approach at SAI Med Partners.
Filter By
All Resources
- Blog
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Jason Tardio, President and […]
- Blog
Welcome to a special edition of IDEA Collider’s “Deep Medicine” series. In this episode, host Alex Gray sits down with […]
- Blog
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior […]
- White Paper
Our Best Practices for Tracking Research. Tracking research is a foundational part of any market research plan. Studies under the […]
- White Paper
An accurate prediction of future market share can help optimize strategy beyond sales and marketing, impacting decisions as far-reaching as […]
- White Paper
A unique Market Research approach to inform rare disease education. The Challenge. One of the common challenges orphan drug makers […]
- White Paper
Healthcare marketing now recognizes that prescribing decisions—like all decisions—are never purely rational. But the search to identify heuristics and other […]
- White Paper
We all appreciate the importance of empathy in patient interactions. However, this understanding is even more important in the world […]
- Blog
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray is joined by IDEA Pharma colleagues David Radwaner and […]
- Blog
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is […]
Let’s Talk Business
Explore our Related Solutions: Delve Deeper
Gain further understanding of our range of related solutions and offerings by exploring each topic individually.